COVID-19 screening, prognosis and severity assessment with biomarkers for management of patients
Résumé
This global epidemic of coronavirus that we are currently experiencing, need an over view on the biological markers that allow the monitoring of COVID-19 disease.
After a synopsis of the clinical characteristics and the management of patients, we propose a literature review of the diagnostic tests which include molecular and serological diagnosis. The aim of this document is to show the biological
markers involved in screening, triage and prognosis, which involves white blood cells, platelets, Ddimer, CRP and fibrinogen.
While acknowledging that these parameters are not exhaustive, they nonetheless represent essential biological markers for the management of this epidemic
Origine | Fichiers produits par l'(les) auteur(s) |
---|
Loading...